Nihal Sinha

London, England, UK

Bio

Professional summary

Nihal Sinha is a London-based Partner at F-Prime focused primarily on biotech and life sciences in Europe and the U.S. At F-Prime, he was a member of the founding team of Orchard Therapeutics and an investor in Ensoma, Curie Bio, Charm Therapeutics, Aviado Bio, and T-Therapeutics. Before joining F-Prime in 2013, he worked as a strategy consultant at BCG and as an academic physician at Oxford University and UCL Hospitals.

Notable companies

Selected portfolio companies the partner has backed

Orchard TherapeuticsEnsomaCurie BioCharm TherapeuticsAviado Bio

Background

Career, education, and skills

Career history

F-Prime CapitalPartner2013 – Present
Boston Consulting GroupStrategy Consultant
Oxford UniversityAcademic Physician
UCL HospitalsAcademic Physician

Education

University of CambridgeMB BChir with distinction
Royal College of PhysiciansMember of the Royal College of Physicians

Other partners at F-Prime

12 more profiles

View firm →

Abdul Abdirahman

Principal

F-Prime

Principal investing in early-stage B2B software, fintech, and vertical SaaS.

B2B softwareEarly-stage investingEmerging marketsFintechVertical SaaS

Alex Pasteur

Partner

F-Prime

Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.

Life SciencesTherapeutics

Anastasiya Sybirna, PhD

Senior Associate

F-Prime

Senior Associate on F-Prime's London healthcare investment team.

BiopharmaHealthcareLife sciencesPharmaceuticalsTherapeutics

Bala Varadhan

Principal

F-Prime

Principal focused on early-stage crypto, blockchain and Web3 investments.

BlockchainCryptoDigital assetsEarly-stage investingWeb3

Benjamin Gorman

Principal

F-Prime

Principal investing in early-stage enterprise software and AI.

AIDataEarly-stage investingEnterprise softwareMachine learning

Betsy Mulé

Principal

F-Prime

Principal investing in enterprise technology and robotics.

B2B softwareEarly-stage investingEnterprise technologyFrontier technologyRobotics

Brett Cook

Partner

F-Prime

F-Prime Partner investing in healthcare technology and services companies.

care deliverydigital healthhealthcare datahealthcare serviceshealthcare technology

Brian Yordy

Principal

F-Prime

Principal investing in biopharmaceutical and medical technology companies.

BiopharmaceuticalsHealthcareLife sciencesMedical technologyTherapeutics

Carl Bradford Byers 🚑

Partner

F-Prime

F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.

digital healthfintechhealthcare IThealthcare serviceshealthtech

Carl Byers

Partner

F-Prime

Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.

HealthtechServices

Chance Mathisen

Associate

F-Prime

Associate focused on early-stage enterprise software investments.

AIEarly-stage investingEnterprise softwareGo-to-market strategySoftware platforms

Chong Xu

Partner

F-Prime

F-Prime partner focused on biopharma, medtech, company formation, and China healthcare opportunities.

BiopharmaceuticalsChina healthcareCompany formationHealthcare investingMedical technology

See something out of date?

Suggest a correction — our team reviews every edit.

Improve this profile